Brett Sandercock - 10 Feb 2022 Form 4 Insider Report for RESMED INC (RMD)

Role: Chief Financial Officer
Signature: Brett Sandercock, Chief Financial Officer
Issuer symbol: RMD
Transactions as of: 10 Feb 2022
Net transactions value: -$460,250
Form type: 4
Filing time: 14 Feb 2022, 11:59:57 UTC
Previous filing: 11 Jan 2022
Next filing: 14 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RMD	ResMed Common Stock	Options Exercise	$144,400	+2,500	+2.4%	$57.76	108,854	10 Feb 2022	Direct	F1
transaction	RMD	ResMed Common Stock	Sale	$604,650	-2,500	-2.3%	$241.86	106,354	10 Feb 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RMD	ResMed Common Stock Options	Options Exercise	$0	-2,500	-14%	$0.000000	15,000	10 Feb 2022	ResMed Common Stock	2,500	$57.76	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transaction was conducted under a Rule 10b5-1 plan.
F2	Represents date options first became exercisable. Options vest 1/3 per year.